文献速递产科母胎医学

单绒毛膜双羊膜囊双胎选择性胎儿生长受限合并脐动脉舒张末期血流持续或间歇性缺失或反向的国际多中心队列研究结局

Outcome of monochorionic diamniotic twin pregnancy with selective fetal growth restriction and continuous or intermittent absent or reversed end-diastolic umbilical artery flow: international multicenter cohort study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-05-29

国际多中心回顾性队列研究纳入2016-2022年5个胎儿医学中心的363例单绒毛膜双羊膜囊双胎选择性胎儿生长受限孕妇,评估脐动脉舒张末期血流持续或间歇性缺失或反向的胎儿及新生儿结局,并比较选择性减胎与期待治疗后大胎结局。

要点

  • 脐动脉血流模式在59%的妊娠期间发生变化。
  • 最终超声显示持续缺失或反向的小胎存活率70%,存活者中29%发生严重新生儿疾病。
  • 选择性减胎与大胎32周后活产概率提高32-34%相关。

核心结论

  • 单绒毛膜双羊膜囊双胎合并选择性胎儿生长受限及脐动脉舒张末期血流持续或间歇性缺失或反向者,胎儿死亡和严重疾病风险高,尤其持续缺失或反向的小胎。
  • 与期待治疗相比,选择性减胎显著提高大胎32周后无严重疾病存活的机会,可能受出生孕周增加影响。

研究设计与样本

  • 国际回顾性队列研究,纳入5个胎儿医学中心2016-2022年7年间的单绒毛膜双羊膜囊双胎妊娠,选择性胎儿生长受限合并脐动脉舒张末期血流持续或间歇性缺失或反向,基于估计胎儿体重差异≥20%纳入,共363例妊娠(726胎儿),初始诊断持续缺失或反向124例、间歇性缺失或反向239例。

主要发现

  • 脐动脉血流模式在59%的妊娠期间发生变化。
  • 最终超声显示持续缺失或反向的小胎存活率70%,存活者中29%发生严重新生儿疾病;该组大胎存活率87%,存活者中26%发生严重新生儿疾病。
  • 最终超声显示间歇性缺失或反向的小胎存活率83%,存活者中22%发生严重新生儿疾病;该组大胎存活率87%,存活者中13%发生严重新生儿疾病。
  • 小胎持续缺失或反向的不良结局(胎儿或新生儿死亡或严重新生儿疾病)合计风险为52%,间歇性缺失或反向为37%。
  • 37例自然胎儿死亡中24例(65%)为双胎死亡;单胎死亡后存活者中约30%发生严重脑损伤。

关键数值与推荐

  • 选择性减胎与期待治疗相比,大胎32周后活产概率提高32-34%。

临床怎么用

  • 研究数据可用于患者咨询和管理决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Monochorionic diamniotic (MCDA) twins with selective fetal growth restriction (sFGR) and either continuous (cAREDF) or intermittent (iAREDF) absent or reversed end-diastolic flow in the umbilical artery face significant fetal and neonatal risks. This study evaluated fetal and neonatal outcomes in these cases and compared outcomes for the larger twin following selective reduction (SR) vs expectant management (EM). METHODS: This was an international retrospective cohort study of MCDA twin pregnancies with sFGR and cAREDF or iAREDF from five fetal medicine centers over 7 years (2016-2022). Patients were included based on an estimated fetal weight (EFW) discordance of ≥ 20% combined with cAREDF or iAREDF. We collected demographic and antenatal characteristics, longitudinal ultrasound and management data, and key perinatal outcomes, including gestational age (GA) at birth, survival rate and severe neonatal morbidity. Outcomes for the larger twin following SR vs EM were compared using logistic regression with standardization, inverse probability weighting and augmented inverse probability weighting to adjust for confounders. Average treatment effects (risk differences) were calculated for three composite outcomes (live birth at ≥ 32 weeks; live birth at ≥ 32 weeks and absence of severe neonatal morbidity; and live birth without a GA limit and absence of severe neonatal morbidity) and overall live birth. RESULTS: Data were analyzed from 363 MCDA twin pregnancies (726 fetuses) with sFGR, which were diagnosed initially as having either cAREDF (n = 124) or iAREDF (n = 239). The umbilical artery flow pattern changed in 59% of pregnancies during gestation. Smaller twins with cAREDF at the final ultrasound scan before demise, delivery or intervention had a 70% survival rate, with 29% of survivors experiencing severe neonatal morbidity. In contrast, larger twins in this group had an 87% survival rate and a 26% risk of severe neonatal morbidity among survivors. For smaller twins with iAREDF at the final ultrasound scan, the survival rate was 83% and 22% of survivors were affected by severe neonatal morbidity, whereas larger twins had an 87% survival rate and a 13% risk of severe neonatal morbidity among survivors. The combined risk of adverse outcomes (fetal or neonatal demise or severe neonatal morbidity) was 52% for smaller twins with cAREDF and 37% for those with iAREDF. Among 37 cases of spontaneous fetal demise, 24 (65%) were double demise. Severe cerebral injury following single fetal demise occurred in approximately 30% of survivors. SR was associated with a 32-34% higher probability of the larger twin being liveborn ≥ 32 weeks compared with EM. This benefit seemed to align with later GA at birth and reduced rate of severe neonatal morbidity, despite similar rates of live birth. CONCLUSIONS: MCDA twins with sFGR and cAREDF or iAREDF are at high risk for demise and severe morbidity, particularly the smaller twin with cAREDF. Compared with EM, SR significantly improves the chance of the larger twin being born at ≥ 32 weeks and surviving without severe morbidity, which may be influenced by increased GA at birth. These data should inform patient counseling and management decisions. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Noll ATR, van Hoogstraten A, Nulens K, et al. Outcome of monochorionic diamniotic twin pregnancy with selective fetal growth restriction and continuous or intermittent absent or reversed end-diastolic umbilical artery flow: international multicenter cohort study. Ultrasound Obstet Gynecol. 2025. PMID: 40443107. doi:10.1002/uog.29241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。